Analysis Of Safety From A Human Clinical Trial With Pterostilbene
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 215 |
| Gender | Both Genders |
| Age Range | 45-64 |
A safety study using 125mg pterostilbene twice daily (250mg each day) for 52 days in hypercholesterolemic adults failed to find any adverse effects on liver enzymes and other serum biomarkers of toxicity, suggesting its safety.
